Cartalax is a regulatory peptide complex associated with cartilage and connective-tissue motif research. Its sequence composition supports studies of chondrocyte signaling, extracellular-matrix synthesis, and redox balance in vitro. Researchers monitor structural integrity and receptor engagement under physiological conditions. Applications include tissue-regeneration modeling, peptide-therapy mechanistic work, and matrix-peptide interaction analysis.
CAT No: Z10-101-225
Synonyms/Alias:Ala-Glu-Asp; alanyl-glutamyl-aspartic acid; Cartalax; T-31 peptide; H-Ala-Glu-Asp-OH; SCHEMBL5324601; CHEBI:158137; GLXC-25918; L-Alanyl-L-glutamyl-L-aspartic acid; (2S)-2-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-4-carboxybutanoyl]amino]butanedioic acid
Cartalax, a synthetic peptide complex derived from the regulatory peptides of cartilage tissue, has garnered significant attention for its unique bioactive properties and potential research applications. As a short-chain peptide, Cartalax is designed to interact specifically with cellular structures associated with cartilage and connective tissues. Its sequence is engineered to mimic the natural regulatory peptides found in healthy cartilage, enabling it to modulate cellular processes relevant to tissue maintenance and repair. The stability and solubility of Cartalax make it a favorable candidate for in vitro and ex vivo studies, where precise control over experimental conditions is essential. Researchers value its ability to be easily incorporated into various assay systems, supporting investigations into the molecular mechanisms underlying cartilage physiology and pathology.
Cartilage Regeneration Research: Cartalax is widely utilized in studies focused on cartilage regeneration and repair. By providing a model peptide that closely resembles endogenous regulatory factors, it enables scientists to probe the signaling pathways involved in chondrocyte proliferation, matrix synthesis, and tissue remodeling. This research is fundamental for understanding how cartilage maintains its structure and function under physiological and stress conditions. The peptide's compatibility with cell culture systems allows for detailed analysis of gene expression and protein synthesis relevant to cartilage health, offering valuable insights for regenerative medicine and tissue engineering fields.
Connective Tissue Metabolism: In the context of connective tissue metabolism, Cartalax serves as a valuable tool for elucidating the molecular mechanisms that govern the synthesis and degradation of extracellular matrix components. Researchers employ this peptide to investigate how specific signaling cascades influence the turnover of collagen, proteoglycans, and other structural proteins within joint and connective tissues. Such studies are critical for unraveling the complex interplay between anabolic and catabolic processes, which has direct implications for understanding degenerative conditions and developing strategies to support tissue integrity.
Inflammatory Response Modulation: The role of Cartalax in modulating inflammatory responses within joint environments is another important area of application. Scientists use it to examine how peptide-based interventions can alter the expression of cytokines, chemokines, and other mediators involved in inflammation. By studying these interactions, researchers can gain a deeper understanding of the cellular and molecular events that contribute to tissue damage and repair following injury or in chronic inflammatory states. This knowledge is instrumental in identifying novel therapeutic targets and optimizing anti-inflammatory strategies for joint health research.
Aging and Cartilage Homeostasis: Investigations into the effects of aging on cartilage homeostasis frequently incorporate Cartalax as a model compound. Its ability to mimic regulatory signals allows researchers to study age-associated changes in chondrocyte function, extracellular matrix composition, and tissue resilience. Through these studies, scientists can better characterize the molecular events that lead to the decline in cartilage quality with age, providing a foundation for developing interventions aimed at preserving joint function and preventing age-related degeneration.
Biomarker Discovery and Mechanistic Studies: Cartalax is also leveraged in biomarker discovery and mechanistic studies related to cartilage biology. By utilizing this peptide in controlled experimental setups, researchers can identify specific genes, proteins, or metabolites that are responsive to peptide signaling. These findings contribute to the development of novel diagnostic tools and enhance the understanding of the underlying biology of cartilage maintenance and disease. The versatility of Cartalax in these research applications underscores its value as an indispensable resource for advancing the scientific knowledge of cartilage and connective tissue biology.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More